RhumbLine Advisers’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.99M | Buy |
89,881
+3,039
| +3% | +$101K | ﹤0.01% | 1667 |
|
|
2025
Q1 | $2.54M | Sell |
86,842
-7,666
| -8% | -$225K | ﹤0.01% | 1693 |
|
|
2024
Q4 | $3.11M | Buy |
94,508
+285
| +0.3% | +$9.37K | ﹤0.01% | 1652 |
|
|
2024
Q3 | $4.19M | Sell |
94,223
-6,957
| -7% | -$309K | ﹤0.01% | 1521 |
|
|
2024
Q2 | $4.36M | Sell |
101,180
-970
| -0.9% | -$41.8K | ﹤0.01% | 1468 |
|
|
2024
Q1 | $2.99M | Buy |
102,150
+1,652
| +2% | +$48.3K | ﹤0.01% | 1692 |
|
|
2023
Q4 | $2.24M | Sell |
100,498
-1,624
| -2% | -$36.2K | ﹤0.01% | 1844 |
|
|
2023
Q3 | $2.53M | Buy |
102,122
+1,240
| +1% | +$30.7K | ﹤0.01% | 1748 |
|
|
2023
Q2 | $2.86M | Buy |
100,882
+9,477
| +10% | +$268K | ﹤0.01% | 1706 |
|
|
2023
Q1 | $2.1M | Buy |
91,405
+2,137
| +2% | +$49.1K | ﹤0.01% | 1782 |
|
|
2022
Q4 | $2.51M | Buy |
89,268
+2,322
| +3% | +$65.2K | ﹤0.01% | 1663 |
|
|
2022
Q3 | $2.46M | Buy |
86,946
+5,291
| +6% | +$150K | ﹤0.01% | 1644 |
|
|
2022
Q2 | $1.81M | Buy |
81,655
+6,199
| +8% | +$137K | ﹤0.01% | 1816 |
|
|
2022
Q1 | $2.2M | Sell |
75,456
-6,309
| -8% | -$184K | ﹤0.01% | 1768 |
|
|
2021
Q4 | $2.69M | Sell |
81,765
-4,239
| -5% | -$139K | ﹤0.01% | 1723 |
|
|
2021
Q3 | $3.97M | Sell |
86,004
-2,545
| -3% | -$117K | 0.01% | 1490 |
|
|
2021
Q2 | $4.88M | Buy |
88,549
+19,331
| +28% | +$1.07M | 0.01% | 1440 |
|
|
2021
Q1 | $3.57M | Sell |
69,218
-1,866
| -3% | -$96.3K | ﹤0.01% | 1595 |
|
|
2020
Q4 | $3.08M | Buy |
71,084
+3,430
| +5% | +$149K | ﹤0.01% | 1630 |
|
|
2020
Q3 | $2.37M | Sell |
67,654
-2,129
| -3% | -$74.5K | ﹤0.01% | 1579 |
|
|
2020
Q2 | $3.73M | Buy |
69,783
+5,916
| +9% | +$316K | 0.01% | 1373 |
|
|
2020
Q1 | $2.27M | Buy |
63,867
+15,281
| +31% | +$542K | ﹤0.01% | 1481 |
|
|
2019
Q4 | $2.32M | Buy |
48,586
+4,086
| +9% | +$195K | ﹤0.01% | 1717 |
|
|
2019
Q3 | $1.44M | Buy |
44,500
+1,368
| +3% | +$44.3K | ﹤0.01% | 1881 |
|
|
2019
Q2 | $2.15M | Sell |
43,132
-7,431
| -15% | -$371K | ﹤0.01% | 1705 |
|
|
2019
Q1 | $3.41M | Sell |
50,563
-245
| -0.5% | -$16.5K | 0.01% | 1394 |
|
|
2018
Q4 | $2.34M | Sell |
50,808
-1,808
| -3% | -$83.4K | 0.01% | 1544 |
|
|
2018
Q3 | $4.06M | Sell |
52,616
-746
| -1% | -$57.5K | 0.01% | 1243 |
|
|
2018
Q2 | $4.5M | Buy |
53,362
+3,211
| +6% | +$270K | 0.01% | 1169 |
|
|
2018
Q1 | $4.1M | Buy |
50,151
+5,029
| +11% | +$411K | 0.01% | 1168 |
|
|
2017
Q4 | $2.58M | Sell |
45,122
-663
| -1% | -$37.9K | 0.01% | 1478 |
|
|
2017
Q3 | $3.06M | Sell |
45,785
-497
| -1% | -$33.2K | 0.01% | 1337 |
|
|
2017
Q2 | $2.38M | Buy |
46,282
+9,374
| +25% | +$482K | 0.01% | 1470 |
|
|
2017
Q1 | $2.16M | Buy |
36,908
+961
| +3% | +$56.1K | 0.01% | 1508 |
|
|
2016
Q4 | $1.5M | Buy |
35,947
+6,147
| +21% | +$257K | ﹤0.01% | 1617 |
|
|
2016
Q3 | $1.57M | Buy |
29,800
+985
| +3% | +$52K | ﹤0.01% | 1563 |
|
|
2016
Q2 | $1.21M | Buy |
28,815
+4,574
| +19% | +$192K | ﹤0.01% | 1666 |
|
|
2016
Q1 | $984K | Sell |
24,241
-706
| -3% | -$28.7K | ﹤0.01% | 1811 |
|
|
2015
Q4 | $1.62M | Buy |
24,947
+605
| +2% | +$39.3K | 0.01% | 1497 |
|
|
2015
Q3 | $1.72M | Buy |
24,342
+736
| +3% | +$51.9K | 0.01% | 1411 |
|
|
2015
Q2 | $2.62M | Buy |
23,606
+7,880
| +50% | +$876K | 0.01% | 1231 |
|
|
2015
Q1 | $1.48M | Buy |
15,726
+3,005
| +24% | +$283K | ﹤0.01% | 1606 |
|
|
2014
Q4 | $1.43M | Buy |
12,721
+1,371
| +12% | +$154K | ﹤0.01% | 1571 |
|
|
2014
Q3 | $696K | Sell |
11,350
-640
| -5% | -$39.2K | ﹤0.01% | 2005 |
|
|
2014
Q2 | $549K | Buy |
+11,990
| New | +$549K | ﹤0.01% | 2218 |
|